Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases
Antisense oligonucleotides (ASOs) are single-stranded nucleic acid strings that can be used to selectively modify protein synthesis by binding complementary (pre-)mRNA sequences. By specific arrangements of DNA and RNA into a chain of nucleic acids and additional modifications of the backbone, sugar...
Saved in:
Main Authors: | Jacob Helm (Author), Ludger Schöls (Author), Stefan Hauser (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons
by: Stefan Hauser, et al.
Published: (2022) -
Allele-Selective Knockdown of MYH7 Using Antisense Oligonucleotides
by: Brian R. Anderson, et al.
Published: (2020) -
Fluorinated Nucleotide Modifications Modulate Allele Selectivity of SNP-Targeting Antisense Oligonucleotides
by: Michael E. Østergaard, et al.
Published: (2017) -
Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1
by: Tobias Bonifert, et al.
Published: (2016) -
Tissue pharmacokinetics of antisense oligonucleotides
by: Erica Bäckström, et al.
Published: (2024)